Risk of acute kidney injury from oral acyclovir: A population-based study

American Journal of Kidney Diseases

Volumn 61, Issue 5, 2013, Pages 723-729

  Lam, Ngan N ^a   Weir, Matthew A ^a   Yao, Zhan ^b   Blake, Peter G ^a   Beyea, Michael M ^a,c   Gomes, Tara ^b,c   Gandhi, Sonja ^a   Mamdani, Muhammad ^b,c,d,e   Wald, Ron ^e   Parikh, Chirag R ^f   Hackam, Daniel G ^a   Garg, Amit X ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; acyclovir; drug nephrotoxicity

Indexed keywords

ACICLOVIR; FAMCICLOVIR; VALACICLOVIR;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; POPULATION RESEARCH; PRESCRIPTION; RISK FACTOR; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ACYCLOVIR; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CREATININE; FEMALE; HERPES SIMPLEX; HERPES ZOSTER; HUMANS; MALE; ONTARIO; OUTPATIENTS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84876292695     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.12.008     Document Type: Article

References (36)

1. M. Abudalu, S. Tyring, W. Koltun, N. Bodsworth, K. Hamed Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial Clin Infect Dis 47 5 2008 651 658
2. S.K. Tyring, K.R. Beutner, B.A. Tucker, W.C. Anderson, R.J. Crooks Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older Arch Fam Med 9 9 2000 863 869
3. K.R. Beutner, D.J. Friedman, C. Forszpaniak, P.L. Andersen, M.J. Wood Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults Antimicrob Agents Chemother 39 7 1995 1546 1553
4. B. Bean, D. Aeppli Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster J Infect Dis 151 2 1985 362 365
5. H. Izzedine, V. Launay-Vacher, G. Deray Antiviral drug-induced nephrotoxicity Am J Kidney Dis 45 5 2005 804 817
6. W.J. Mason, H.H. Nickols Images in clinical medicine Crystalluria from acyclovir use N Engl J Med 358 13 2008 e14
7. Acyclovir (systemic): drug information D.S. Basow UpToDate 2012 UpToDate Waltham, MA
8. R. Fleischer, M. Johnson Acyclovir nephrotoxicity: a case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy Case Report Med 2010 2010 pii:602783
9. P.K. Sodhi, S.K. Ratan A case of chronic renal dysfunction following treatment with oral acyclovir Scand J Infect Dis 35 10 2003 770 772
10. A.F. Lawson, P.A. Green, A.S. Brett Acute renal insufficiency due to oral acyclovir in a man with sickle cell trait South Med J 92 11 1999 1093 1094
11. J. Bradley, N. Forero, H. Pho, B. Escobar, B.S. Kasinath, A. Anzueto Progressive somnolence leading to coma in a 68-year-old man Chest 112 2 1997 538 540
12. G.L. Johnson, L. Limon, G. Trikha, H. Wall Acute renal failure and neurotoxicity following oral acyclovir Ann Pharmacother 28 4 1994 460 463
13. P. Eck, S.M. Silver, E.C. Clark Acute renal failure and coma after a high dose of oral acyclovir N Engl J Med 325 16 1991 1178 1179
14. D.M. Roberts, M.W. Smith, B.J. McMullan, J. Sevastos, R.O. Day Acute kidney injury due to crystalluria following acute valacyclovir overdose Kidney Int 79 5 2011 574
15. T. Asahi, M. Tsutsui, M. Wakasugi Valacyclovir neurotoxicity: clinical experience and review of the literature Eur J Neurol 16 4 2009 457 460
16. T. Sugimoto, M. Yasuda, M. Sakaguchi Oliguric acute renal failure following oral valacyclovir therapy QJM 101 2 2008 164 166
17. R. Carlon, C. Possamai, U. Corbanese Acute renal failure and severe neurotoxicity following valacyclovir Intensive Care Med 31 11 2005 1593
18. J.C. Huff, B. Bean, H.H. Balfour Jr Therapy of herpes zoster with oral acyclovir Am J Med 85 2A 1988 84 89
19. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gøtzsche, J.P. Vandenbroucke STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies J Clin Epidemiol 61 4 2008 344 349
20. A.R. Levy, B.J. O'Brien, C. Sellors, P. Grootendorst, D. Willison Coding accuracy of administrative drug claims in the Ontario Drug Benefit database Can J Clin Pharmacol 10 2 2003 67 71
21. Y.Y. Zhao, M.A. Weir, M. Manno New fibrate use and acute renal outcomes in elderly adults: a population-based study Ann Intern Med 156 8 2012 560 569
22. A.W. Shih, M.A. Weir, K.K. Clemens Oral bisphosphonate use in the elderly is not associated with acute kidney injury Kidney Int 82 8 2012 903 908
23. R. Saltzman, R. Jurewicz, R. Boon Safety of famciclovir in patients with herpes zoster and genital herpes Antimicrob Agents Chemother 38 10 1994 2454 2457
24. R. Engst, U. Schiewe, W. Höbel, K. Machka, W. Meister Famciclovir in treatment of acute herpes zoster: results of two post-marketing surveillance studies in Germany Acta Derm Venereol 81 1 2001 59 60
25. T.H. Htwe, S. Bergman, J. Koirala Famciclovir substitution for patients with acyclovir-associated renal toxicity J Infect 57 3 2008 266 268
26. S.S. Waikar, R. Wald, G.M. Chertow Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure J Am Soc Nephrol 17 6 2006 1688 1694
27. R. Bellomo, C. Ronco, J.A. Kellum, R.L. Mehta, P. Palevsky Acute Dialysis Quality Initiative Workgroup Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group Crit Care 8 4 2004 R204 R212
28. R.L. Mehta, J.A. Kellum, S.V. Shah Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 2 2007 R31
29. Z. Ricci, D. Cruz, C. Ronco The RIFLE criteria and mortality in acute kidney injury: a systematic review Kidney Int 73 5 2008 538 546
30. G.M. Chertow, E. Burdick, M. Honour, J.V. Bonventre, D.W. Bates Acute kidney injury, mortality, length of stay, and costs in hospitalized patients J Am Soc Nephrol 16 11 2005 3365 3370
31. M.A. Perazella Crystal-induced acute renal failure Am J Med 106 4 1999 459 465
32. S.G. Yarlagadda, M.A. Perazella Drug-induced crystal nephropathy: an update Expert Opin Drug Saf 7 2 2008 147 158
33. Valacyclovir: drug information D.S. Basow UpToDate 2012 UpToDate Waltham, MA
34. Famciclovir: drug information D.S. Basow UpToDate 2012 UpToDate Waltham, MA
35. P. de Miranda, M.R. Blum Pharmacokinetics of acyclovir after intravenous and oral administration J Antimicrob Chemother 12 suppl B 1983 29 37
36. O.L. Laskin Clinical pharmacokinetics of acyclovir Clin Pharmacokinet 8 3 1983 187 201